O
FRX

OrbiMed’s FOREST LABORATORIES INC FRX Stock Holding History

OrbiMed’s Portfolio FRX Stock Details FRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-97,000
Closed -$9.6M – 158
2014
Q2 		$9.6M Buy
97,000
+3,000
+3% +$280K 0.11% 87
2014
Q1 		$8.67M Sell
94,000
-45,000
-32% -$3.63M 0.11% 99
2013
Q4 		$8.34M Buy
139,000
+19,000
+16% +$956K 0.12% 87
2013
Q3 		$5.13M Hold
120,000
– – 0.09% 98
2013
Q2 		$4.92M Buy
+120,000
New +$4.64M 0.1% 100

Other funds holding FRX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return

OrbiMed's FRX Position: Q3 2014 in Review

OrbiMed sold out of FOREST LABORATORIES INC (FRX) in Q3 2014, closing a stake of 97,000 shares — an estimated $9.6M sold.

OrbiMed first reported a position in FRX in Q2 2013 and held it in 5 quarters. The position peaked at $9.6M in Q2 2014. 5 funds tracked by Wall St. Rank hold FRX as of Q3 2014.

  • OrbiMed reported no remaining FOREST LABORATORIES INC position as of Q3 2014 after selling out during the quarter.
  • OrbiMed sold 97,000 FOREST LABORATORIES INC shares in Q3 2014, an estimated $9.6M.
  • OrbiMed first reported a position in FOREST LABORATORIES INC in Q2 2013 and held it in 5 quarters.
  • OrbiMed's FOREST LABORATORIES INC position peaked at $9.6M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held FOREST LABORATORIES INC as of Q3 2014.

Based on OrbiMed's 13F filing for Q3 2014, filed 14 Nov 2014.